Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
NCT01525199
·
clinicaltrials.gov ↗
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class
Conditions
Stage IIIB/IV
Non-Small Cell Lung Cancer
Sponsor
AstraZeneca